Fermentas International Overview
- Founded
-
1975
- Status
-
Acquired/Merged
- Employees
-
500
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Fermentas International General Information
Description
Manufacturer of molecular biological products. The company offers restriction enzymes, DNA/RNA modifying enzymes, restriction enzymes, molecular cloning, nucleic acid purification, molecular labeling and detection, RNA and DNA electrophoresis products, nucleotides and primers, transfection reagents, and reagents.
Contact Information
Website
www.fermentas.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
- 830 Harrington Court
- Burlington, Ontario L7N 3N4
- Canada
+1 (905) 000-0000
Fermentas International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fermentas International Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Viktoras Butkus Ph.D | Chairman & Chief Executive Officer | ||
| Gerhard Gerber Ph.D | President |
Fermentas International Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000000 000000 00 | Fermentas International | Chairman & Chief Executive Officer | 000 0000 |
Fermentas International Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Fermentas International Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|